-
1
-
-
22344457187
-
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy
-
Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Matsuda M, Arase Y, Ikeda K, Kumada H. 2005. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. Intervirology 48: 372-380.
-
(2005)
Intervirology
, vol.48
, pp. 372-380
-
-
Akuta, N.1
Suzuki, F.2
Sezaki, H.3
Suzuki, Y.4
Hosaka, T.5
Someya, T.6
Kobayashi, M.7
Saitoh, S.8
Watahiki, S.9
Sato, J.10
Matsuda, M.11
Arase, Y.12
Ikeda, K.13
Kumada, H.14
-
2
-
-
33846593397
-
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
-
Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Arase Y, Ikeda K, Kumada H. 2007a. Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. J Hepatol 46: 403-410.
-
(2007)
J Hepatol
, vol.46
, pp. 403-410
-
-
Akuta, N.1
Suzuki, F.2
Kawamura, Y.3
Yatsuji, H.4
Sezaki, H.5
Suzuki, Y.6
Hosaka, T.7
Kobayashi, M.8
Arase, Y.9
Ikeda, K.10
Kumada, H.11
-
3
-
-
34748866821
-
Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
-
Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Arase Y, Ikeda K, Kumada H. 2007b. Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b. J Med Virol 79: 1686-1695.
-
(2007)
J Med Virol
, vol.79
, pp. 1686-1695
-
-
Akuta, N.1
Suzuki, F.2
Kawamura, Y.3
Yatsuji, H.4
Sezaki, H.5
Suzuki, Y.6
Hosaka, T.7
Kobayashi, M.8
Arase, Y.9
Ikeda, K.10
Kumada, H.11
-
4
-
-
60049090076
-
A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: Amino acid substitutions in HCV core region as predictor of sustained virological response
-
Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. 2009. A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: Amino acid substitutions in HCV core region as predictor of sustained virological response. J Med Virol 81: 452-458.
-
(2009)
J Med Virol
, vol.81
, pp. 452-458
-
-
Akuta, N.1
Suzuki, F.2
Hirakawa, M.3
Kawamura, Y.4
Yatsuji, H.5
Sezaki, H.6
Suzuki, Y.7
Hosaka, T.8
Kobayashi, M.9
Saitoh, S.10
Arase, Y.11
Ikeda, K.12
Kumada, H.13
-
5
-
-
77955691994
-
Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin
-
Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Chayama K, Nakamura Y, Kumada H. 2010. Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. Hepatology 52: 421-429.
-
(2010)
Hepatology
, vol.52
, pp. 421-429
-
-
Akuta, N.1
Suzuki, F.2
Hirakawa, M.3
Kawamura, Y.4
Yatsuji, H.5
Sezaki, H.6
Suzuki, Y.7
Hosaka, T.8
Kobayashi, M.9
Saitoh, S.10
Arase, Y.11
Ikeda, K.12
Chayama, K.13
Nakamura, Y.14
Kumada, H.15
-
6
-
-
0036775519
-
A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging
-
Averbook BJ, Fu P, Rao JS, Mansour EG. 2002. A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging. Surgery 132: 589-602.
-
(2002)
Surgery
, vol.132
, pp. 589-602
-
-
Averbook, B.J.1
Fu, P.2
Rao, J.S.3
Mansour, E.G.4
-
7
-
-
0038789160
-
Phosphorus ans an early predictive factor in patients with acute liver failure
-
Baquerizo A, Anselmo D, Shackleton C, Chen TW, Cao C, Weaver M, Gornbein J, Geevarghese S, Nissen N, Farmer D, Demetriou A, Busuttil RW. 2003. Phosphorus ans an early predictive factor in patients with acute liver failure. Transplantation 75: 2007-2014.
-
(2003)
Transplantation
, vol.75
, pp. 2007-2014
-
-
Baquerizo, A.1
Anselmo, D.2
Shackleton, C.3
Chen, T.W.4
Cao, C.5
Weaver, M.6
Gornbein, J.7
Geevarghese, S.8
Nissen, N.9
Farmer, D.10
Demetriou, A.11
Busuttil, R.W.12
-
8
-
-
0029778988
-
An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group
-
Bedossa P, Poynard T. 1996. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293.
-
(1996)
Hepatology
, vol.24
, pp. 289-293
-
-
Bedossa, P.1
Poynard, T.2
-
10
-
-
0041822106
-
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
-
Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J. 2003. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 38: 645-652.
-
(2003)
Hepatology
, vol.38
, pp. 645-652
-
-
Davis, G.L.1
Wong, J.B.2
McHutchison, J.G.3
Manns, M.P.4
Harvey, J.5
Albrecht, J.6
-
11
-
-
0029161576
-
Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region
-
Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96: 224-230.
-
(1995)
J Clin Invest
, vol.96
, pp. 224-230
-
-
Enomoto, N.1
Sakuma, I.2
Asahina, Y.3
Kurosaki, M.4
Murakami, T.5
Yamamoto, C.6
Izumi, N.7
Marumo, F.8
Sato, C.9
-
12
-
-
9144257569
-
Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
-
Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334: 77-81.
-
(1996)
N Engl J Med
, vol.334
, pp. 77-81
-
-
Enomoto, N.1
Sakuma, I.2
Asahina, Y.3
Kurosaki, M.4
Murakami, T.5
Yamamoto, C.6
Ogura, Y.7
Izumi, N.8
Marumo, F.9
Sato, C.10
-
13
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Jr., Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Goncales Jr, F.L.6
Haussinger, D.7
Diago, M.8
Carosi, G.9
Dhumeaux, D.10
Craxi, A.11
Lin, A.12
Hoffman, J.13
Yu, J.14
-
14
-
-
22344444621
-
Improved detection of prostate cancer using classification and regression tree analysis
-
Garzotto M, Beer TM, Hudson RG, Peters L, Hsieh YC, Barrera E, Klein T, Mori M. 2005. Improved detection of prostate cancer using classification and regression tree analysis. J Clin Oncol 23: 4322-4329.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4322-4329
-
-
Garzotto, M.1
Beer, T.M.2
Hudson, R.G.3
Peters, L.4
Hsieh, Y.C.5
Barrera, E.6
Klein, T.7
Mori, M.8
-
15
-
-
70349292099
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
-
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
-
(2009)
Nature
, vol.461
, pp. 399-401
-
-
Ge, D.1
Fellay, J.2
Thompson, A.J.3
Simon, J.S.4
Shianna, K.V.5
Urban, T.J.6
Heinzen, E.L.7
Qiu, P.8
Bertelsen, A.H.9
Muir, A.J.10
Sulkowski, M.11
McHutchison, J.G.12
Goldstein, D.B.13
-
16
-
-
65449171953
-
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection
-
Hezode C, Forestier N, Dusheiko G, Ferenci P, Pol S, Goeser T, Bronowicki JP, Bourliere M, Gharakhanian S, Bengtsson L, McNair L, George S, Kieffer T, Kwong A, Kauffman RS, Alam J, Pawlotsky JM, Zeuzem S. 2009. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med 360: 1839-1850.
-
(2009)
N Engl J Med
, vol.360
, pp. 1839-1850
-
-
Hezode, C.1
Forestier, N.2
Dusheiko, G.3
Ferenci, P.4
Pol, S.5
Goeser, T.6
Bronowicki, J.P.7
Bourliere, M.8
Gharakhanian, S.9
Bengtsson, L.10
McNair, L.11
George, S.12
Kieffer, T.13
Kwong, A.14
Kauffman, R.S.15
Alam, J.16
Pawlotsky, J.M.17
Zeuzem, S.18
-
17
-
-
68349144495
-
Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response
-
Ikeda H, Suzuki M, Okuse C, Yamada N, Okamoto M, Kobayashi M, Nagase Y, Takahashi H, Matsunaga K, Matsumoto N, Itoh F, Yotsuyanagi H, Koitabashi Y, Yasuda K, Iino S. 2009. Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response. Hepatol Res 39: 753-759.
-
(2009)
Hepatol Res
, vol.39
, pp. 753-759
-
-
Ikeda, H.1
Suzuki, M.2
Okuse, C.3
Yamada, N.4
Okamoto, M.5
Kobayashi, M.6
Nagase, Y.7
Takahashi, H.8
Matsunaga, K.9
Matsumoto, N.10
Itoh, F.11
Yotsuyanagi, H.12
Koitabashi, Y.13
Yasuda, K.14
Iino, S.15
-
18
-
-
77954382326
-
Management of hepatitis C; Report of the consensus meeting at the 45th annual meeting of the Japan society of hepatology (2009)
-
Izumi N, Nishiguchi S, Hino K, Suzuki F, Kumada Y, Itoh Y, Asahina Y, Tamori A, Hiramatsu N, Hayashi N, Kudo M. 2010. Management of hepatitis C; Report of the consensus meeting at the 45th annual meeting of the Japan society of hepatology (2009). Hepatol Res 40: 347-368.
-
(2010)
Hepatol Res
, vol.40
, pp. 347-368
-
-
Izumi, N.1
Nishiguchi, S.2
Hino, K.3
Suzuki, F.4
Kumada, Y.5
Itoh, Y.6
Asahina, Y.7
Tamori, A.8
Hiramatsu, N.9
Hayashi, N.10
Kudo, M.11
-
19
-
-
33646590308
-
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy
-
Jensen DM, Morgan TR, Marcellin P, Pockros PJ, Reddy KR, Hadziyannis SJ, Ferenci P, Ackrill AM, Willems B. 2006. Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology 43: 954-960.
-
(2006)
Hepatology
, vol.43
, pp. 954-960
-
-
Jensen, D.M.1
Morgan, T.R.2
Marcellin, P.3
Pockros, P.J.4
Reddy, K.R.5
Hadziyannis, S.J.6
Ferenci, P.7
Ackrill, A.M.8
Willems, B.9
-
20
-
-
0031042869
-
Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy
-
Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C, Ogura Y. 1997. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 25: 750-753.
-
(1997)
Hepatology
, vol.25
, pp. 750-753
-
-
Kurosaki, M.1
Enomoto, N.2
Murakami, T.3
Sakuma, I.4
Asahina, Y.5
Yamamoto, C.6
Ikeda, T.7
Tozuka, S.8
Izumi, N.9
Marumo, F.10
Sato, C.11
Ogura, Y.12
-
21
-
-
77954369987
-
A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis
-
Kurosaki M, Matsunaga K, Hirayama I, Tanaka T, Sato M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Ikeda H, Itakura J, Takahashi Y, Asahina Y, Higak M, Enomoto N, Izumi N. 2010a. A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis. Hepatol Res 40: 251-260.
-
(2010)
Hepatol Res
, vol.40
, pp. 251-260
-
-
Kurosaki, M.1
Matsunaga, K.2
Hirayama, I.3
Tanaka, T.4
Sato, M.5
Yasui, Y.6
Tamaki, N.7
Hosokawa, T.8
Ueda, K.9
Tsuchiya, K.10
Nakanishi, H.11
Ikeda, H.12
Itakura, J.13
Takahashi, Y.14
Asahina, Y.15
Higak, M.16
Enomoto, N.17
Izumi, N.18
-
22
-
-
79954420891
-
Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
-
DOI: 10.1007/s00535-010-0322-5.
-
Kurosaki M, Sakamoto N, Iwasaki M, Sakamoto M, Suzuki Y, Hiramatsu N, Sugauchi F, Yatsuhashi H, Izumi N. 2010b. Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis. J Gastroenterol DOI: 10.1007/s00535-010-0322-5.
-
(2010)
J Gastroenterol
-
-
Kurosaki, M.1
Sakamoto, N.2
Iwasaki, M.3
Sakamoto, M.4
Suzuki, Y.5
Hiramatsu, N.6
Sugauchi, F.7
Yatsuhashi, H.8
Izumi, N.9
-
23
-
-
78851469540
-
Pretreatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors
-
DOI: 10.1016/j.jhep.2010.07.037.
-
Kurosaki M, Tanaka Y, Nishida N, Sakamoto N, Enomoto N, Honda M, Sugiyama M, Matsuura K, Sugauchi F, Asahina Y, Nakagawa M, Watanabe M, Sakamoto M, Maekawa S, Sakai A, Kaneko S, Ito K, Masaki N, Tokunaga K, Izumi N, Mizokami M. 2010c. Pretreatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. J Hepatol DOI: 10.1016/j.jhep.2010.07.037.
-
(2010)
J Hepatol
-
-
Kurosaki, M.1
Tanaka, Y.2
Nishida, N.3
Sakamoto, N.4
Enomoto, N.5
Honda, M.6
Sugiyama, M.7
Matsuura, K.8
Sugauchi, F.9
Asahina, Y.10
Nakagawa, M.11
Watanabe, M.12
Sakamoto, M.13
Maekawa, S.14
Sakai, A.15
Kaneko, S.16
Ito, K.17
Masaki, N.18
Tokunaga, K.19
Izumi, N.20
Mizokami, M.21
more..
-
24
-
-
0029177148
-
A review of tree-based prognostic models
-
LeBlanc M, Crowley J. 1995. A review of tree-based prognostic models. Cancer Treat Res 75: 113-124.
-
(1995)
Cancer Treat Res
, vol.75
, pp. 113-124
-
-
LeBlanc, M.1
Crowley, J.2
-
25
-
-
42149136216
-
Optimizing outcomes in patients with hepatitis C virus genotype 1 or 4
-
Lee SS, Ferenci P. 2008. Optimizing outcomes in patients with hepatitis C virus genotype 1 or 4. Antivir Ther 13: 9-16.
-
(2008)
Antivir Ther
, vol.13
, pp. 9-16
-
-
Lee, S.S.1
Ferenci, P.2
-
26
-
-
4644305972
-
Prognostic factors of thin cutaneous melanoma: An analysis of the central malignant melanoma registry of the German Dermatological Society
-
Leiter U, Buettner PG, Eigentler TK, Garbe C. 2004. Prognostic factors of thin cutaneous melanoma: An analysis of the central malignant melanoma registry of the German Dermatological Society. J Clin Oncol 22: 3660-3667.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3660-3667
-
-
Leiter, U.1
Buettner, P.G.2
Eigentler, T.K.3
Garbe, C.4
-
27
-
-
77952730427
-
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection
-
Li JH, Lao XQ, Tillmann HL, Rowell J, Patel K, Thompson A, Suchindran S, Muir AJ, Guyton JR, Gardner SD, McHutchison JG, McCarthy JJ. 2010. Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection. Hepatology 51: 1904-1911.
-
(2010)
Hepatology
, vol.51
, pp. 1904-1911
-
-
Li, J.H.1
Lao, X.Q.2
Tillmann, H.L.3
Rowell, J.4
Patel, K.5
Thompson, A.6
Suchindran, S.7
Muir, A.J.8
Guyton, J.R.9
Gardner, S.D.10
McHutchison, J.G.11
McCarthy, J.J.12
-
28
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 358: 958-965.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
Goodman, Z.D.7
Koury, K.8
Ling, M.9
Albrecht, J.K.10
-
29
-
-
65449152185
-
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection
-
McHutchison JG, Everson GT, Gordon SC, Jacobson IM, Sulkowski M, Kauffman R, McNair L, Alam J, Muir AJ. 2009. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med 360: 1827-1838.
-
(2009)
N Engl J Med
, vol.360
, pp. 1827-1838
-
-
McHutchison, J.G.1
Everson, G.T.2
Gordon, S.C.3
Jacobson, I.M.4
Sulkowski, M.5
Kauffman, R.6
McNair, L.7
Alam, J.8
Muir, A.J.9
-
30
-
-
0036559582
-
Novel statistical classification model of type 2 diabetes mellitus patients for tailor-made prevention using data mining algorithm
-
Miyaki K, Takei I, Watanabe K, Nakashima H, Omae K. 2002. Novel statistical classification model of type 2 diabetes mellitus patients for tailor-made prevention using data mining algorithm. J Epidemiol 12: 243-248.
-
(2002)
J Epidemiol
, vol.12
, pp. 243-248
-
-
Miyaki, K.1
Takei, I.2
Watanabe, K.3
Nakashima, H.4
Omae, K.5
-
31
-
-
45749153381
-
Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses
-
Munoz de Rueda P, Casado J, Paton R, Quintero D, Palacios A, Gila A, Quiles R, Leon J, Ruiz-Extremera A, Salmeron J. 2008. Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses. J Virol 82: 6644-6653.
-
(2008)
J Virol
, vol.82
, pp. 6644-6653
-
-
Munoz de Rueda, P.1
Casado, J.2
Paton, R.3
Quintero, D.4
Palacios, A.5
Gila, A.6
Quiles, R.7
Leon, J.8
Ruiz-Extremera, A.9
Salmeron, J.10
-
32
-
-
0024511418
-
A comparison of estimated proportional hazards models and regression trees
-
Segal MR, Bloch DA. 1989. A comparison of estimated proportional hazards models and regression trees. Stat Med 8: 539-550.
-
(1989)
Stat Med
, vol.8
, pp. 539-550
-
-
Segal, M.R.1
Bloch, D.A.2
-
33
-
-
58149380829
-
Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors
-
Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, Umemura T, Ichijo T, Yoshizawa K, Kiyosawa K, Tanaka E. 2008. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology 48: 1753-1760.
-
(2008)
Hepatology
, vol.48
, pp. 1753-1760
-
-
Shirakawa, H.1
Matsumoto, A.2
Joshita, S.3
Komatsu, M.4
Tanaka, N.5
Umemura, T.6
Ichijo, T.7
Yoshizawa, K.8
Kiyosawa, K.9
Tanaka, E.10
-
34
-
-
0033919082
-
Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: How does this modify the treatment course?
-
Shiratori Y, Omata M. 2000. Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: How does this modify the treatment course? J Gastroenterol Hepatol 15: E141-E151.
-
(2000)
J Gastroenterol Hepatol
, vol.15
-
-
Shiratori, Y.1
Omata, M.2
-
35
-
-
70349548852
-
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
-
Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Muller T, Bahlo M, Stewart GJ, Booth DR, George J. 2009. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
-
(2009)
Nat Genet
, vol.41
, pp. 1100-1104
-
-
Suppiah, V.1
Moldovan, M.2
Ahlenstiel, G.3
Berg, T.4
Weltman, M.5
Abate, M.L.6
Bassendine, M.7
Spengler, U.8
Dore, G.J.9
Powell, E.10
Riordan, S.11
Sheridan, D.12
Smedile, A.13
Fragomeli, V.14
Muller, T.15
Bahlo, M.16
Stewart, G.J.17
Booth, D.R.18
George, J.19
-
36
-
-
70349533037
-
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
-
Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. 2009. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
-
(2009)
Nat Genet
, vol.41
, pp. 1105-1109
-
-
Tanaka, Y.1
Nishida, N.2
Sugiyama, M.3
Kurosaki, M.4
Matsuura, K.5
Sakamoto, N.6
Nakagawa, M.7
Korenaga, M.8
Hino, K.9
Hige, S.10
Ito, Y.11
Mita, E.12
Tanaka, E.13
Mochida, S.14
Murawaki, Y.15
Honda, M.16
Sakai, A.17
Hiasa, Y.18
Nishiguchi, S.19
Koike, A.20
Sakaida, I.21
Imamura, M.22
Ito, K.23
Yano, K.24
Masaki, N.25
Sugauchi, F.26
Izumi, N.27
Tokunaga, K.28
Mizokami, M.29
more..
-
37
-
-
33845641397
-
Prognostic groups in colorectal carcinoma patients based on tumor cell proliferation and classification and regression tree (CART) survival analysis
-
Valera VA, Walter BA, Yokoyama N, Koyama Y, Iiai T, Okamoto H, Hatakeyama K. 2007. Prognostic groups in colorectal carcinoma patients based on tumor cell proliferation and classification and regression tree (CART) survival analysis. Ann Surg Oncol 14: 34-40.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 34-40
-
-
Valera, V.A.1
Walter, B.A.2
Yokoyama, N.3
Koyama, Y.4
Iiai, T.5
Okamoto, H.6
Hatakeyama, K.7
-
38
-
-
46249114151
-
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial
-
Yu ML, Dai CY, Huang JF, Chiu CF, Yang YH, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Wang LY, Chang WY, Chuang WL. 2008. Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial. Hepatology 47: 1884-1893.
-
(2008)
Hepatology
, vol.47
, pp. 1884-1893
-
-
Yu, M.L.1
Dai, C.Y.2
Huang, J.F.3
Chiu, C.F.4
Yang, Y.H.5
Hou, N.J.6
Lee, L.P.7
Hsieh, M.Y.8
Lin, Z.Y.9
Chen, S.C.10
Wang, L.Y.11
Chang, W.Y.12
Chuang, W.L.13
-
39
-
-
23044492303
-
A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods
-
Zlobec I, Steele R, Nigam N, Compton CC. 2005. A predictive model of rectal tumor response to preoperative radiotherapy using classification and regression tree methods. Clin Cancer Res 11: 5440-5443.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 5440-5443
-
-
Zlobec, I.1
Steele, R.2
Nigam, N.3
Compton, C.C.4
|